DigestRedComo funciona
Red
/
Empresas
On
No verificado

Ono Pharmaceutical Co., Ltd.

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

7 Comunicados de prensa

Ver todos los comunicados de prensa
09/10/2025
Ciencia
Medicina - Varios
Biotecnología
Sanidad
Salud
Farmacéutica
Oncología
Industria
Ono Announces ONO-4578 (EP4 antagonist) in Combination with Opdivo and Chemotherapy Met the Primary Endpoint in a Phase 2 Clinical Trial in Patients with Certain Gastric Cancer
Fuente
Ono Pharmaceutical Co., Ltd.
Editor
Business Wire
1.00
0
09/10/2025
Biotecnología
Farmacéutica
Salud
Medicina - Varios
Ono Announces Encouraging Efficacy Signals of ONO-2808, a S1P5 Receptor Agonist, in an interim analysis of Ongoing Phase 2 Clinical Trial in Patients with Multiple System Atrophy
Fuente
Ono Pharmaceutical Co., Ltd.
Editor
Business Wire
1.00
0
23/06/2025
Biotecnología
Salud
Farmacéutica
Medicina - Varios
Mercado laboral
Industria
Ono Pharmaceutical and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea
Fuente
Ono Pharmaceutical Co., Ltd.
Editor
Business Wire
1.00
0
28/05/2025
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Biotecnología
Eventos
Industria
ONO PHARMA Presents Positive Results From Pivotal Trial in U.S. Patients With Relapsed or Refractory PCNSL at 2025 ASCO Annual Meeting
Fuente
Ono Pharmaceutical Co., Ltd.
Editor
Business Wire
1.00
0
24/04/2025
Oncología
Salud
Ciencia
Farmacéutica
Biotecnología
Ono Pharma Announces an Oral Presentation on Phase 2 Data for Tirabrutinib and a Poster Session on ONO-4578 (EP4 Antagonist) at the American Society of Clinical Oncology (ASCO) Annual Meeting
Fuente
Ono Pharmaceutical Co., Ltd.
Editor
Business Wire
1.00
0
21/04/2025
Industria
Ciencia
Técnica
Medicina - Varios
Biotecnología
Farmacéutica
Salud
Oncología
Ono Commences Research Collaboration with Jorna Therapeutics to Generate Novel RNA Editing Therapeutics
Fuente
Ono Pharmaceutical Co., Ltd.
Editor
Business Wire
1.00
0
11/03/2025
Mercado laboral
Industria
Ciencia
Biotecnología
Farmacéutica
Oncología
Salud
Medicina - Varios
Ono Enters into License Agreement with Ionis Pharmaceuticals for Sapablursen for the Treatment of Polycythemia Vera
Fuente
Ono Pharmaceutical Co., Ltd.
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0